ELISA Method Development and Validation
For novel protein therapeutics, we will design, develop, and validate custom immunoassays using the antibody of your choice, or of commercial origin. If needed, we can also assist with the generation of custom/novel antibodies against your protein therapeutic. For assays developed in non-GLP laboratories, we can transfer and validate them at Swiss BioQuant under GLP regulations.
ELISA Kit Validation
We will qualify or validate commercially available ELISA/EIA kits for your preclinical or clinical sample analysis needs. This includes identifying the best available assay kit and evaluating it for compatibility with your peptide or protein.
Automated ELISA Validation & Sample Analysis
Using liquid handling and robotic pipetting technologies we are able to automate ELISA methods, avoiding extraction of samples for measurement. This allows us to streamline sample analysis while also providing maximum accuracy, reproducibility, and fast data turnaround times.
Stringent in house immunoassay development and validation processes ensure the highest possible ELISA performance. ELISA protocols can be validated to support preclinical and clinical studies for analysis in a wide variety of matrices.